Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Report 2026
Download Free Sample Buy Now
Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Report 2026

Global Outlook – By Type of Therapy (Gene Augmentation, Immunotherapy, Other Type of Therapy), By Type of Gene Delivery Method Used (Ex Vivo, In Vivo), By Scale of Operation (Preclinical, Clinical, Commercial), By Target Therapeutic Area (Genetic Disorders, Hematological Disorders, Infectious Diseases, Metabolic Disorders, Ophthalmic Disorders, Muscle Disorders, Neurological Disorders, Other Target Therapeutic Area) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Overview

• Adeno-Associated Virus (AVV) Vectors In Gene Therapy market size has reached to $3.16 billion in 2025

• Expected to grow to $6.99 billion in 2030 at a compound annual growth rate (CAGR) of 17.2%

• Growth Driver: Surge In Gene-based Therapies Fueling The Growth Of The Market Due To Rising Demand For Precise And Long-term Genetic Treatments

• Market Trend: Strengthening Manufacturing Consistency In Advanced Therapies

• North America was the largest region in 2025.

What Is Covered Under Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market?

Adeno-associated virus (AAV) vectors in gene therapy are advanced delivery tools that transport genetic material into cells to treat various genetic disorders. Their primary goal is to enable targeted, long-lasting therapeutic effects by correcting or modifying faulty genes. AAV vectors are valued for their safety, low immunogenicity, and ability to deliver genes to both dividing and non-dividing cells, supporting the development of precise and durable gene therapies that advance personalized medicine and transform the treatment of rare and inherited diseases.

The main types of adeno-associated virus (AVV) vectors are gene augmentation, immunotherapy, and other kind of therapy. Gene augmentation refers to the therapeutic introduction of a functional gene into a cell to replace or compensate for a defective or missing one. This can be performed using different gene delivery methods, such as ex vivo, and in vivo. This is conducted at various scales of operation, including preclinical, clinical, and commercial. The target therapeutic areas include genetic disorders, hematological disorders, infectious diseases, metabolic disorders, ophthalmic disorders, muscle disorders, and neurological conditions.

Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Global Report 2026 Market Report bar graph

What Is The Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Size and Share 2026?

The adeno-associated virus (avv) vectors in gene therapy market size has grown rapidly in recent years. It will grow from $3.16 billion in 2025 to $3.7 billion in 2026 at a compound annual growth rate (CAGR) of 17.3%. The growth in the historic period can be attributed to advancements in viral vector safety, rare genetic disorder research, clinical gene therapy success, regulatory approvals, academic research investments.

What Is The Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Growth Forecast?

The adeno-associated virus (avv) vectors in gene therapy market size is expected to see rapid growth in the next few years. It will grow to $6.99 billion in 2030 at a compound annual growth rate (CAGR) of 17.2%. The growth in the forecast period can be attributed to commercial gene therapy launches, scalable vector production demand, precision medicine expansion, orphan drug incentives, global clinical trial growth. Major trends in the forecast period include expansion of gene augmentation therapies, rising demand for rare disease gene treatments, growth of in vivo gene delivery, increased commercial-scale vector manufacturing, focus on long-term therapeutic durability.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Segmentation

1) By Type of Therapy: Gene Augmentation, Immunotherapy, Other Type of Therapy

2) By Type of Gene Delivery Method Used: Ex Vivo, In Vivo

3) By Scale of Operation: Preclinical, Clinical, Commercial

4) By Target Therapeutic Area: Genetic Disorders, Hematological Disorders, Infectious Diseases, Metabolic Disorders, Ophthalmic Disorders, Muscle Disorders, Neurological Disorders, Other Target Therapeutic Area

Subsegments:

1) By Gene Augmentation: Monogenic Disorders, Neurological Disorders, Muscular Disorders, Ophthalmological Disorders, Metabolic Disorders

2) By Immunotherapy: Oncology, Infectious Diseases, Autoimmune Disorders, Vaccine Development, T-Cell Engineering

3) By Other Type of Therapy: Gene Editing Support, RNA Interference, Neuroprotection and Neuroregeneration, Anti-Inflammatory Applications, Regenerative Medicine

What Is The Driver Of The Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market?

The increasing focus on gene-based therapies is expected to propel the growth of the adeno-associated virus (AAV) vectors in the gene therapy market going forward. Gene-based therapies are treatments that modify or manipulate genes to prevent, treat, or cure diseases at the molecular level. Advancements in genetic research drive the increasing focus on creating gene-based therapies, as they enhance the precision and effectiveness of gene editing techniques. Adeno-associated virus (AAV) vectors in gene therapy help create gene-based therapies by delivering therapeutic genes safely and efficiently into target cells, owing to their low immunogenicity and ability to provide long-term gene expression. For instance, in 2023, according to IQVIA, a US-based provider of advanced analytics and technology solutions for the life sciences industry, global spending on cell and gene therapies reached $5.9 billion, representing a 38% increase from 2022. Therefore, increasing focus on creating gene-based therapies is driving the growth of the adeno-associated virus (AAV) vectors market.

Key Players In The Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

Major companies operating in the adeno-associated virus (avv) vectors in gene therapy market are F. Hoffmann-La Roche Ltd., Sanofi S.A., Novartis AG, Astellas Gene Therapies Inc., Biogen Inc., Sarepta Therapeutics Inc., Oxford BioMedica plc, Rocket Pharmaceuticals Inc., Aldevron LLC, REGENXBIO Inc., uniQure N.V., Passage Bio Inc., Voyager Therapeutics Inc., Dyno Therapeutics Inc., MeiraGTx Holdings plc, Abeona Therapeutics Inc., 4D Molecular Therapeutics Inc., GenSight Biologics S.A., Taysha Gene Therapies Inc., LogicBio Therapeutics Inc.

Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Trends and Insights

Major companies operating in the adeno-associated virus (AAV) vectors in the gene therapy market are focusing on advanced innovation, such as tailored vector diversity for assay versatility to enhance target tissue specificity, improve therapeutic efficacy, and accelerate the development of customized gene therapies across various indications. Tailored vector diversity for assay versatility refers to using multiple AAV serotypes or constructs to support various analytical tests and therapeutic applications. For instance, in May 2024, Charles River Laboratories, a US-based pharmaceutical company, introduced new reference materials for adeno-associated virus (AAV) and lentiviral vectors (LVV). These materials are intended to support the growing needs of cell and gene therapy (CGT) development. The portfolio facilitates a smoother transition from early-stage research to GMP-grade production. It helps standardize processes and improve consistency in viral vector manufacturing. This launch addresses a key challenge in scaling CGT programs toward clinical and commercial readiness.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market?

In March 2023, Ginkgo Bioworks, a US-based biotech company, acquired StrideBio's AAV capsid discovery and engineering platform assets for an undisclosed amount. With this acquisition, Ginkgo Bioworks aims to enhance its end-to-end research and development capabilities in gene therapy, particularly developing novel adeno-associated virus (AVV) capsids for improved gene delivery. StrideBio is a US-based biotechnology company focused on developing engineered AAV capsids for gene therapy applications.

Regional Insights

North America was the largest region in the adeno-associated virus (AVV) vectors in gene therapy market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market?

The adeno-associated virus (AAV) vectors in gene therapy market consists of revenues earned by entities by providing services such as gene delivery solutions, targeted therapeutic development, long-term gene expression, and treatment of genetic disorders through safe and efficient viral vector technologies. The market value includes the value of related goods sold by the service provider or included within the service offering. The adeno-associated virus (AAV) vectors in gene therapy market includes sales of viral vector delivery systems used for transporting genetic material into patient cells. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Report 2026?

The adeno-associated virus (avv) vectors in gene therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the adeno-associated virus (avv) vectors in gene therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $3.7 billion
Revenue Forecast In 2035 $6.99 billion
Growth Rate CAGR of 17.3% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type of Therapy, Type of Gene Delivery Method Used, Scale of Operation, Target Therapeutic Area
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled F. Hoffmann-La Roche Ltd., Sanofi S.A., Novartis AG, Astellas Gene Therapies Inc., Biogen Inc., Sarepta Therapeutics Inc., Oxford BioMedica plc, Rocket Pharmaceuticals Inc., Aldevron LLC, REGENXBIO Inc., uniQure N.V., Passage Bio Inc., Voyager Therapeuti
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Expansion Of Gene Augmentation Therapies

4.2.2 Rising Demand For Rare Disease Gene Treatments

4.2.3 Growth Of In Vivo Gene Delivery

4.2.4 Increased Commercial-Scale Vector Manufacturing

4.2.5 Focus On Long-Term Therapeutic Durability

5. Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Analysis Of End Use Industries

5.1 Biopharmaceutical Companies

5.2 Contract Development And Manufacturing Organizations

5.3 Research Institutions

5.4 Gene Therapy Centers

5.5 Clinical Trial Facilities

6. Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Size, Comparisons And Growth Rate Analysis

7.3. Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Segmentation

9.1. Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Gene Augmentation, Immunotherapy, Other Type of Therapy

9.2. Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ex Vivo, In Vivo

9.3. Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Preclinical, Clinical, Commercial

9.4. Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Genetic Disorders, Hematological Disorders, Infectious Diseases, Metabolic Disorders, Ophthalmic Disorders, Muscle Disorders, Neurological Disorders, Other Target Therapeutic Area

9.5. Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Sub-Segmentation Of Gene Augmentation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monogenic Disorders, Neurological Disorders, Muscular Disorders, Ophthalmological Disorders, Metabolic Disorders

9.6. Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oncology, Infectious Diseases, Autoimmune Disorders, Vaccine Development, T-Cell Engineering

9.7. Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Sub-Segmentation Of Other Type of Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Gene Editing Support, RNA Interference, Neuroprotection and Neuroregeneration, Anti-Inflammatory Applications, Regenerative Medicine

10. Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Regional And Country Analysis

10.1. Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

11.1. Asia-Pacific Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Segmentation By Type of Gene Delivery Method Used, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

12.1. China Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Segmentation By Type of Gene Delivery Method Used, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

13.1. India Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Segmentation By Type of Gene Delivery Method Used, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

14.1. Japan Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Segmentation By Type of Gene Delivery Method Used, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

15.1. Australia Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Segmentation By Type of Gene Delivery Method Used, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

16.1. Indonesia Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Segmentation By Type of Gene Delivery Method Used, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

17.1. South Korea Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Segmentation By Type of Gene Delivery Method Used, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

18.1. Taiwan Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Segmentation By Type of Gene Delivery Method Used, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

19.1. South East Asia Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Segmentation By Type of Gene Delivery Method Used, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

20.1. Western Europe Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Segmentation By Type of Gene Delivery Method Used, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

21.1. UK Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Segmentation By Type of Gene Delivery Method Used, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

22.1. Germany Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Segmentation By Type of Gene Delivery Method Used, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

23.1. France Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Segmentation By Type of Gene Delivery Method Used, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

24.1. Italy Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Segmentation By Type of Gene Delivery Method Used, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

25.1. Spain Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Segmentation By Type of Gene Delivery Method Used, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

26.1. Eastern Europe Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Segmentation By Type of Gene Delivery Method Used, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

27.1. Russia Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Segmentation By Type of Gene Delivery Method Used, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

28.1. North America Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Segmentation By Type of Gene Delivery Method Used, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

29.1. USA Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Segmentation By Type of Gene Delivery Method Used, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

30.1. Canada Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Segmentation By Type of Gene Delivery Method Used, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

31.1. South America Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Segmentation By Type of Gene Delivery Method Used, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

32.1. Brazil Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Segmentation By Type of Gene Delivery Method Used, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

33.1. Middle East Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Segmentation By Type of Gene Delivery Method Used, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

34.1. Africa Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Segmentation By Type of Gene Delivery Method Used, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Regulatory and Investment Landscape

36. Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Competitive Landscape And Company Profiles

36.1. Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Company Profiles

36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Astellas Gene Therapies Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Other Major And Innovative Companies

Sarepta Therapeutics Inc., Oxford BioMedica plc, Rocket Pharmaceuticals Inc., Aldevron LLC, REGENXBIO Inc., uniQure N.V., Passage Bio Inc., Voyager Therapeutics Inc., Dyno Therapeutics Inc., MeiraGTx Holdings plc, Abeona Therapeutics Inc., 4D Molecular Therapeutics Inc., GenSight Biologics S.A., Taysha Gene Therapies Inc., LogicBio Therapeutics Inc.

38. Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market

40. Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market High Potential Countries, Segments and Strategies

40.1 Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market In 2030 - Countries Offering Most New Opportunities

40.2 Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market In 2030 - Segments Offering Most New Opportunities

40.3 Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Overview Of Key Products - Product Examples
  • Table 2: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Supply Chain Analysis
  • Table 4: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Major Raw Material Providers
  • Table 5: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Major Resource Providers
  • Table 6: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Major Manufacturers (Suppliers)
  • Table 7: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Major Distributors And Channel Partners
  • Table 8: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Key Technologies & Future Trends
  • Table 9: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Major Trends
  • Table 10: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Major End Users
  • Table 11: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market - TAM, US$ Billion, 2025
  • Table 15: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Sub-Segmentation Of Gene Augmentation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Sub-Segmentation Of Other Type of Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market - Company Scoring Matrix
  • Table 98: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 99: Sanofi S.A. Financial Performance
  • Table 100: Novartis AG Financial Performance
  • Table 101: Astellas Gene Therapies Inc. Financial Performance
  • Table 102: Biogen Inc. Financial Performance
  • Table 103: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Competitive Dashboard
  • Table 105: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Size Gain ($ Billion), Segmentation By Type of Therapy, 2025 – 2030
  • Table 107: Global, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Size Gain ($ Billion), Segmentation By Type of Gene Delivery Method Used, 2025 – 2030
  • Table 108: Global, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Size Gain ($ Billion), Segmentation By Scale of Operation, 2025 – 2030

List Of Figures

    Figure 1: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Supply Chain Analysis
  • Figure 4: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Major Raw Material Providers
  • Figure 5: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Major Resource Providers
  • Figure 6: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Major Distributors And Channel Partners
  • Figure 8: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Key Technologies & Future Trends
  • Figure 9: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Major Trends
  • Figure 10: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Major End Users
  • Figure 11: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market - TAM, US$ Billion, 2025
  • Figure 15: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Sub-Segmentation Of Gene Augmentation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Sub-Segmentation Of Other Type of Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Type of Gene Delivery Method Used, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market - Company Scoring Matrix
  • Figure 98: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 99: Sanofi S.A. Financial Performance
  • Figure 100: Novartis AG Financial Performance
  • Figure 101: Astellas Gene Therapies Inc. Financial Performance
  • Figure 102: Biogen Inc. Financial Performance
  • Figure 103: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Competitive Dashboard
  • Figure 105: Global Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Size Gain ($ Billion), Segmentation By Type of Therapy, 2025 – 2030
  • Figure 107: Global, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Size Gain ($ Billion), Segmentation By Type of Gene Delivery Method Used, 2025 – 2030
  • Figure 108: Global, Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Size Gain ($ Billion), Segmentation By Scale of Operation, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Adeno-Associated Viral Vectors Market Report 2026 - Global Outlook – By Type Of Therapy (Gene Augmentation, Immunotherapy, Other Type Of Therapies), By Type Of Gene Delivery Method Used (Ex Vivo, In Vivo), By Target Ther...

Nucleic Acid Based Gene Therapy Market Report 2026 - Global Outlook – By Technology (Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologie...

Gene Therapy Market Report 2026 - Global Outlook – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncology, Orphan Disease, Knee Osteoarthritis,...

Antiviral Combination Therapy Market Report 2026 - Global Outlook – By Type (Branded, Generic), By Drug Combination (Nucleotide Reverse Transcriptase Inhibitors/Non-Nucleotide Reverse Transcriptase Inhibitors, Integrase ...

Oral Expectorant Market Report 2026 - Global Outlook – By Drug Type (Secretion Enhancer, Mucolytics), By Dosage Form (Oral Solids, Oral Liquids, Inhalants), By Medication (Prescription drugs, Over The Counter Drugs), By ...

Oncolytic Virus Therapy Market Report 2026 - Global Outlook – By Therapy Type (Herpes Simplex Virus (HSV)-Based Oncolytic Virus Therapy, Adenovirus-Based Oncolytic Virus Therapy, Reovirus, Poxviruses, Newcastle Disease V...

Viral Vector Manufacturing Market Report 2026 - Global Outlook – By Type (Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Other Types), By Disease (Cancer, Genetic Disorders, I...

Viral And Non-Viral Vector Manufacturing Market Report 2026 - Global Outlook – By Vector Type (Viral Vector, Non-Viral Vector), By Disease (Cancer, Genetic Disease, Infectious Disease, Cardiovascular Disease, Other Disea...

Frequently Asked Questions

The Adeno-Associated Virus (AVV) Vectors In Gene Therapy market was valued at $3.16 billion in 2025, increased to $3.7 billion in 2026, and is projected to reach $6.99 billion by 2030.

The global Adeno-Associated Virus (AVV) Vectors In Gene Therapy market is expected to grow at a CAGR of 17.2% from 2026 to 2035 to reach $6.99 billion by 2035.

Some Key Players in the Adeno-Associated Virus (AVV) Vectors In Gene Therapy market Include, F. Hoffmann-La Roche Ltd., Sanofi S.A., Novartis AG, Astellas Gene Therapies Inc., Biogen Inc., Sarepta Therapeutics Inc., Oxford BioMedica plc, Rocket Pharmaceuticals Inc., Aldevron LLC, REGENXBIO Inc., uniQure N.V., Passage Bio Inc., Voyager Therapeutics Inc., Dyno Therapeutics Inc., MeiraGTx Holdings plc, Abeona Therapeutics Inc., 4D Molecular Therapeutics Inc., GenSight Biologics S.A., Taysha Gene Therapies Inc., LogicBio Therapeutics Inc. .

Major trend in this market includes: Strengthening Manufacturing Consistency In Advanced Therapies. For further insights on this market. request a sample here

North America was the largest region in the adeno-associated virus (AVV) vectors in gene therapy market in 2025. The regions covered in the adeno-associated virus (avv) vectors in gene therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us